SARS-CoV-2 evolution during treatment of chronic infection-Reference-Cited by-同舟云学术

SARS-CoV-2 evolution during treatment of chronic infection

Published:2021-02-05 Issue:7853 Volume:592 Page:277-282
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Kemp Steven A., ,Collier Dami A.^ORCID,Datir Rawlings P.,Ferreira Isabella A. T. M.,Gayed Salma,Jahun Aminu^ORCID,Hosmillo Myra,Rees-Spear Chloe,Mlcochova Petra,Lumb Ines Ushiro,Roberts David J.,Chandra Anita,Temperton Nigel^ORCID,Sharrocks Katherine,Blane Elizabeth,Modis Yorgo^ORCID,Leigh Kendra E.,Briggs John A. G.^ORCID,van Gils Marit J.,Smith Kenneth G. C.,Bradley John R.,Smith Chris,Doffinger Rainer,Ceron-Gutierrez Lourdes,Barcenas-Morales Gabriela,Pollock David D.,Goldstein Richard A.^ORCID,Smielewska Anna,Skittrall Jordan P.^ORCID,Gouliouris Theodore,Goodfellow Ian G.,Gkrania-Klotsas Effrossyni^ORCID,Illingworth Christopher J. R.,McCoy Laura E.^ORCID,Gupta Ravindra K.^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-021-03291-y.pdf

Reference50 articles.

1. Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020).

2. Kim, K. W. et al. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing. Preprint at https://doi.org/10.21203/rs.3.rs-105996/v1 (2020).

3. Bull, R. A. et al. Analytical validity of Nanopore sequencing for rapid SARS-CoV-2 genome analysis. Nat. Commun. 11, 6272 (2020).

4. Choi, B. et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 383, 2291–2293 (2020).

5. Avanzato, V. A. et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient. Cell 183, 1901–1912 (2020).

Cited by 838 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to prolonged viral pneumonia in immunocompromised patients with COVID-19;CMI Communications;2024-12

2. Evolution of evolvability in rapidly adapting populations;Nature Ecology & Evolution;2024-09-11

3. SARS-CoV-2 Variants from Long-Term, Persistently Infected Immunocompromised Patients Have Altered Syncytia Formation, Temperature-Dependent Replication, and Serum Neutralizing Antibody Escape;Viruses;2024-09-09

4. Nasopharyngeal specific selection and emergence of SARS-CoV-2 spike fusion peptide mutation P812S during chronic infection;2024-09-06

5. The significance of recurrent de novo amino acid substitutions that emerged during chronic SARS-CoV-2 infection: an observational study;eBioMedicine;2024-09